Bagsværd, Denmark, 1 April 2015 - In continuation of the company's announcements dated 30 October 2014 and 30 January 2015 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S NVO and its wholly-owned affiliates on 31 March 2015 owned 67,108,333 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 13,421,667 or 2.5% of the total share capital.
Further information
Media: | ||
Anne Margrethe Hauge | +45 3079 3450 | amhg@novonordisk.com |
Investors: | ||
Kasper Roseeuw Poulsen | +45 3079 4303 | krop@novonordisk.com |
Daniel Bohsen | +45 3079 6376 | dabo@novonordisk.com |
Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com |
Frank Daniel Mersebach (US) | +1 609 235 8567 | fdni@novonordisk.com |
Company announcement No 25 / 2015
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.